July 23, 2007
Enrollment Completed in PII Trial on NF-kB Decoy Oligo for Atopic Dermatitis: AnGes MG AnGes MG announced on July 9 that the target number of patients has been enrolled in a PII clinical trial of NF-kB decoy oligo which has...read more